Alam Kamran

CIK 00017934122 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001793412

Recent Transactions

32 trades

Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2026-01-12+231,000→ 231,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2026-01-12+359,000→ 1,546,603 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-08-21$2.85/sh−54,491→ 1,187,603 total
Tax Payment
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-03-11$1.69/sh−29,843→ 1,242,094 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-01-02+431,000→ 431,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-01-02+431,000→ 1,271,937 total
Tax Payment
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-02-02$1.51/sh−1,288→ 840,937 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2024-01-02+590,413→ 590,413 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-01-02+590,413→ 842,225 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2023-12-14+187,582→ 187,582 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-08-24$2.33/sh−33,000→ 258,042 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2023-05-31+12,462→ 12,462 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-05-31+6,230→ 291,042 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2023-02-02+149,900→ 149,900 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2023-02-02+37,384→ 37,384 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-02-02+18,691→ 284,812 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-08-23$3.47/sh−3,325→ 266,121 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-08-22$3.50/sh−9,717→ 269,446 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-08-19$3.75/sh−11,482→ 279,163 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-08-18$3.87/sh−7,476→ 290,645 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2022-04-06+40,000→ 40,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2022-02-23+80,000→ 80,000 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-08-20$17.14/sh−2,094→ 298,121 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-08-20$16.70/sh−9,746→ 300,215 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-08-19$17.11/sh−613→ 309,961 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-08-19$16.43/sh−9,354→ 310,574 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-08-18$17.35/sh−11,193→ 319,928 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (Right to Buy)
2021-01-19+70,000→ 70,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2020-09-23+331,121→ 331,121 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2020-02-10+3,000→ 3,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2020-02-06+25,000→ 25,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2019-11-04+200,000→ 200,000 total

Companies

Recent Filings

Address

C/O TAYSHA GENE THERAPIES, INC. 3000 PEGASUS PARK DRIVE, STE 1430

DALLAS, TX, 75247

View on SEC.gov